218 related articles for article (PubMed ID: 23705865)
1. CpG-ODN 7909 increases radiation sensitivity of radiation-resistant human lung adenocarcinoma cell line by overexpression of Toll-like receptor 9.
Yan L; Xu G; Qiao T; Chen W; Yuan S; Li X
Cancer Biother Radiopharm; 2013 Sep; 28(7):559-64. PubMed ID: 23705865
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of radiosensitivity by CpG-oligodeoxyribonucleotide-7909 in human non-small cell lung cancer A549 cells.
Zha L; Qiao T; Yuan S; Lei L
Cancer Biother Radiopharm; 2010 Apr; 25(2):165-70. PubMed ID: 20423229
[TBL] [Abstract][Full Text] [Related]
3. Enhancing radiosensitivity of human pulmonary adenocarcinoma cell line A549 by CpG ODN1826.
Li R; Song Y; Chen W
Cancer Biother Radiopharm; 2011 Feb; 26(1):69-76. PubMed ID: 21355778
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization by CpG ODN7909 in an epidermoid laryngeal carcinoma Hep-2 cell line.
Wang S; Liu X; Qiao T; Zhang Q
J Int Med Res; 2017 Dec; 45(6):2009-2022. PubMed ID: 29239279
[TBL] [Abstract][Full Text] [Related]
5. Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.
Gomez-Casal R; Epperly MW; Wang H; Proia DA; Greenberger JS; Levina V
Oncotarget; 2015 Dec; 6(42):44306-22. PubMed ID: 26517240
[TBL] [Abstract][Full Text] [Related]
6. [Radiosensitizing effect of erlotinib on human lung adenocarcinoma cell line A549].
Liu XQ; Qiao TK
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):819-23. PubMed ID: 24447478
[TBL] [Abstract][Full Text] [Related]
7. The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism.
Zou K; Liu C; Zhang Z; Zou L
Clinics (Sao Paulo); 2015 Aug; 70(8):556-62. PubMed ID: 26247668
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of recombinant human endostatin on the radiosensitivity of human pulmonary adenocarcinoma A549 cells and its mechanism.
Jiang XD; Qiao Y; Dai P; Chen Q; Wu J; Song DA; Li SQ
J Biomed Biotechnol; 2012; 2012():301931. PubMed ID: 22778546
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of radiosensitivity by topoisomerase II inhibitor, amrubicin and amrubicinol, in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction.
Hayashi S; Hatashita M; Matsumoto H; Shioura H; Kitai R; Kano E
Int J Mol Med; 2006 Nov; 18(5):909-15. PubMed ID: 17016621
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition promotes reactivity of human lung adenocarcinoma A549 cells to CpG ODN.
Kobayashi K; Koyama K; Suzukawa M; Igarashi S; Hebisawa A; Nagase T; Ohta K
Allergol Int; 2016 Sep; 65 Suppl():S45-52. PubMed ID: 27475623
[TBL] [Abstract][Full Text] [Related]
11. DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair.
Li Y; Li H; Peng W; He XY; Huang M; Qiu D; Xue YB; Lu L
Mol Med Rep; 2015 Jul; 12(1):1328-34. PubMed ID: 25815686
[TBL] [Abstract][Full Text] [Related]
12. Combination of nadroparin with radiotherapy results in powerful synergistic antitumor effects in lung adenocarcinoma A549 cells.
Zhuang X; Qiao T; Xu G; Yuan S; Zhang Q; Chen X
Oncol Rep; 2016 Oct; 36(4):2200-6. PubMed ID: 27498922
[TBL] [Abstract][Full Text] [Related]
13. miR-511 induces the apoptosis of radioresistant lung adenocarcinoma cells by triggering BAX.
Zhang HH; Pang M; Dong W; Xin JX; Li YJ; Zhang ZC; Yu L; Wang PY; Li BS; Xie SY
Oncol Rep; 2014 Mar; 31(3):1473-9. PubMed ID: 24402374
[TBL] [Abstract][Full Text] [Related]
14. The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway.
Lei Y; Li HX; Jin WS; Peng WR; Zhang CJ; Bu LJ; Du YY; Ma T; Sun GP
Int J Radiat Biol; 2013 Dec; 89(12):1079-86. PubMed ID: 23875954
[TBL] [Abstract][Full Text] [Related]
15. Paris Saponins enhance radiosensitivity in a gefitinib-resistant lung adenocarcinoma cell line by inducing apoptosis and G2/M cell cycle phase arrest.
Zhao PJ; Song SC; Du LW; Zhou GH; Ma SL; Li JH; Feng JG; Zhu XH; Jiang H
Mol Med Rep; 2016 Mar; 13(3):2878-84. PubMed ID: 26846193
[TBL] [Abstract][Full Text] [Related]
16. CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumor.
Yuan S; Qiao T; Chen W
Cancer Biother Radiopharm; 2011 Apr; 26(2):203-8. PubMed ID: 21539452
[TBL] [Abstract][Full Text] [Related]
17. Sanyang Xuedai enhances the radiosensitivity of human non-small cell lung cancer cells via increasing iNOS/NO production.
Wang L; Xia Y; Chen T; Zeng Y; Li L; Hou Y; Li W; Liu Z
Biomed Pharmacother; 2018 Jun; 102():618-625. PubMed ID: 29602129
[TBL] [Abstract][Full Text] [Related]
18. Sensitisation of human lung adenocarcinoma A549 cells to radiotherapy by Nimotuzumab is associated with enhanced apoptosis and cell cycle arrest in the G2/M phase.
Lin S; Yan Y; Liu Y; Gao CZ; Shan D; Li Y; Han B
Cell Biol Int; 2015 Feb; 39(2):146-51. PubMed ID: 25044496
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of c‑Myc activates Fas-mediated apoptosis and sensitizes A549 cells to radiation.
Zhang J; Zhou L; Nan Z; Yuan Q; Wen J; Xu M; Li Y; Li B; Wang P; Liu C; Ma Y; Chen S; Xie S
Oncol Rep; 2017 Oct; 38(4):2471-2479. PubMed ID: 28849062
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cdc25c in cell cycle alteration of a radioresistant lung cancer cell line established with fractionated ionizing radiation.
Li J; Yang CX; Mei ZJ; Chen J; Zhang SM; Sun SX; Zhou FX; Zhou YF; Xie CH
Asian Pac J Cancer Prev; 2013; 14(10):5725-30. PubMed ID: 24289569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]